Trial Profile
Study of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2018
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout
- Focus Adverse reactions; Therapeutic Use
- 19 Jul 2018 New trial record